ART (n = 12) | Control (n = 12) | P value | |
---|---|---|---|
Sex, n (%) | |||
Male | 5 (41.7) | 5 (41.7) | 1a,c |
Female | 7 (58.3) | 7 (58.3) | |
Mean age, y (range) | 43.4 (19–70) | 42.9 (22–62) | 0.924b,c |
Disease stage | |||
I | 2 (16.7) | 1 (8.3) | 1a,c |
II | 5 (41.7) | 6 (50.0) | |
III | 3 (25.0) | 4 (33.3) | |
IV | 2 (16.7) | 1 (8.3) | |
Mitotane use | |||
Yes | 4 (33.3) | 3 (25.0) | 1a,c |
No | 8 (66.7) | 9 (75.0) | |
Ki67 index | |||
< 20% | 4 (33.3) | 5 (41.7) | 0.772a,c |
≥ 20% | 5 (41.7) | 3 (25.0) | |
Not reported | 3 (25.0) | 4 (33.3) | |
Tumor side | |||
Right | 8 (66.7) | 7 (58.3) | 1a,c |
Left | 4 (33.3) | 5 (41.7) | |
Mean tumor size, cm (range) | 7.9 (3–15.3) | 8.4 (4.5–16.5) | 0.688b,c |
Surgical margins | |||
Negative | 6 (50.0) | 8 (66.7) | 0.848a,c |
Positive | 4 (33.3) | 2 (16.7) | |
Not reported | 2 (16.7) | 2 (16.7) |